Target intelligence / Profile preview

Fibroblast growth factor 7 pseudogene 3 (FGF7P3)

Target: FGF7P3
Molecular classification: Other, Pseudogene

Overview

Fibroblast growth factor 7 pseudogene 3 (FGF7P3, KGFLP2) is a human pseudogene. Pseudogenes are genomic DNA fragments similar to known genes but typically nonfunctional, often resulting from gene duplication or retrotransposition. FGF7P3 does not code for a functional fibroblast growth factor or produce a receptor, and there is no evidence that it acts in biological signaling or disease. It is not considered a therapeutic target and does not have a role in drug discovery or clinical diagnostics based on current gene and protein reference sources[1].

Other names: KGFLP2FGF7P3fibroblast growth factor 7 pseudogene 3

Beyond the preview

Go deeper on Fibroblast growth factor 7 pseudogene 3 (FGF7P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast growth factor 7 pseudogene 3 (FGF7P3).

Explore the full profile